HM19

Product Theaters


 

Monday, March 25

12:15 - 1:15 p.m., Product Theater 1
Procalcitonin 2019: Potential and Pitfalls
Speaker: Gregory B. Seymann, MD,
vice chief and professor of hospital medicine,
University of California, San Diego
Sponsored by Thermo Fisher Scientific

12:15 - 1:15 p.m., Product Theater 2
Hospitalization for Heart Failure: A Bad Omen or an Opportunity?
Speakers: Christopher Vagnoni, MD,
hospitalist medical director,
AnMed Medical Center for In Compass Health, Inc., Anderson, S.C.
Patrick McCann, MD, medical director of heart failure
and mechanical circulatory support
Palmetto Health USC Medical Group, Columbia, SC
Sponsored by Novartis Pharmaceuticals Corp.

12:15 - 1:15 p.m., Product Theater 3
Evolution of Select Treatment Options for Patients with Acute Coronary Syndrome or Prior MI
Speaker: John Venditto, MD, MBA,
senior medical director, cardiovascular metabolic disease,
U.S. Medical Affairs – AstraZeneca
Sponsored by AstraZeneca Pharmaceuticals LP


Tuesday, March 26

12:30 - 1:30 p.m., Product Theater 1
Reduction in the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation (NVAF)

Speaker: Charles J. Dow, MD, FACC,
cardiologist, Harvard Medical School, Boston
Sponsored by Pfizer

12:30 - 1:30 p.m., Product Theater 2
Improving Outcomes for Hospitalized Patients with HFrEF: Looking Beyond Stabilization
Speaker: Jennifer Brown, MD
Heart Failure Specialist
Medstar Cardiology Associates
Annapolis, MD
Sponsored by Novartis Pharmaceuticals Corp.

12:30 - 1:30 p.m., Product Theater 3
The Role of the Hospital Medicine Specialist in Managing Transitions of Care in Acute Coronary Syndrome
Speaker: John Venditto, MD, MBA,
senior medical director, cardiovascular metabolic disease,
U.S. Medical Affairs – AstraZeneca
Sponsored by AstraZeneca Pharmaceuticals LP

Next Article:

   Comments ()